Circulating pre-treatment T-cell receptor repertoire as a predictive biomarker in advanced or metastatic non-small-cell lung cancer patients treated with pembrolizumab alone or in combination with chemotherapy
2023 · ESMO Open · 13 citations
https://doi.org/10.1016/j.esmoop.2023.102066